By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ImpediMed Limited

ImpediMed Limited (IPDQF)

OTC Market Data in USD, Fundamentals in AUD
$0.02
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$40.60M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.07
52 Week Range

IPDQF Stock Price Chart

Explore ImpediMed Limited interactive price chart. Choose custom timeframes to analyze IPDQF price movements and trends.

IPDQF Company Profile

Discover essential business fundamentals and corporate details for ImpediMed Limited (IPDQF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

25 Sept 2012

Employees

83.00

CEO

Parmjot Bains

Description

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

IPDQF Financial Timeline

Browse a chronological timeline of ImpediMed Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 24 Feb 2026

Earnings released on 27 Jul 2025

Earnings released on 24 Feb 2025

EPS came in at -$0.00 surpassing the estimated -$0.00 by +88.03%, while revenue for the quarter reached $3.72M , missing expectations by -14.17%.

Earnings released on 21 Oct 2024

EPS came in at -$0.00 surpassing the estimated -$0.00 by +18.00%, while revenue for the quarter reached $3.69M , beating expectations by +0.66%.

Earnings released on 30 Apr 2024

EPS came in at -$0.00 surpassing the estimated -$0.00 by +2.65%, while revenue for the quarter reached $3.26M , missing expectations by -0.33%.

Earnings released on 30 Jun 2023

EPS came in at -$0.00 , while revenue for the quarter reached $3.78M , missing expectations by -5.45%.

Earnings released on 31 Dec 2022

EPS came in at -$0.00 falling short of the estimated -$0.00 by -1.47%, while revenue for the quarter reached $3.86M , missing expectations by -58.77%.

Earnings released on 30 Jun 2022

EPS came in at -$0.00 falling short of the estimated -$0.00 by -2.42%, while revenue for the quarter reached $3.69M , missing expectations by -17.68%.

Earnings released on 31 Dec 2021

EPS came in at -$0.00 surpassing the estimated -$0.01 by +29.48%, while revenue for the quarter reached $3.77M , missing expectations by -2.97%.

Earnings released on 30 Jun 2021

EPS came in at -$0.01 surpassing the estimated -$0.01 by +26.90%, while revenue for the quarter reached $3.63M , missing expectations by -22.09%.

Earnings released on 31 Dec 2020

EPS came in at -$0.01 surpassing the estimated -$0.01 by +29.63%, while revenue for the quarter reached $2.74M , beating expectations by +9.44%.

IPDQF Stock Performance

Access detailed IPDQF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run